SecBot SecBot
144 ·Filed Aug 7, 2026

BLCO

Bausch & Lomb Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001957799-26-000148
Actionable Insight • Neutral

Monitor for actual execution of the sale on Form 4. Given the small size and former director status, no material price impact is expected. The filing does not signal any change in company fundamentals.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$16.83
T+0 close · Aug 7, 2026 · via day close
Latest settled
+19.01%
T+60 · $20.03
Vs SPY
+21.43%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 10 $16.83entry
  2. T+1 · 3mo ago +0.24%α +0.56% · $16.87
  3. T+5 · 3mo ago +1.01%α +1.06% · $17.00
  4. T+20 · 2mo ago +5.35%α +6.26% · $17.73
  5. T+60 · 14d ago +19.01%α +21.43% · $20.03
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Former director Andrew C. Von Eschenbach filed a Form 144 notice of intent to sell 12,500 shares of Bausch & Lomb Corp common stock, valued at approximately $206,193. The shares were acquired through open market purchases in 2025 and 2026. The sale is small relative to BLCO's $5.8B market cap and represents routine portfolio diversification by a former board member.

Key Facts

  • Former director Andrew C. Von Eschenbach intends to sell 12,500 shares of BLCO common stock.
  • Estimated market value of the proposed sale is $206,192.77.
  • Shares were acquired via open market purchases on 05/02/2025 (1,695 shares) and 02/27/2026 (4,364 shares).
  • The filing is a notice of intent, not a completed sale; the sale may or may not occur.
  • The sale represents approximately 0.0035% of BLCO's $5.8B market cap.

Financial Impact

Proposed sale of 12,500 shares valued at ~$206K, negligible relative to $5.8B market cap.

dilution

Risk Factors

  • Insider selling, even small, may be perceived negatively by some market participants.
  • No additional context from other filings to suggest broader insider sentiment.

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
56% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (BLCO), Batch item 10001957799-26-000148
Document: 0001957799-26-000148-index.html0001957799-26-000148
Document: 0001957799-26-000148.txt0001957799-26-000148
144 Filing (BLCO), Batch item 40001957799-26-000148
Document: 0001957799-26-000148-index.html0001957799-26-000148
Document: 0001957799-26-000148.txt0001957799-26-000148

Track record

24 reports on BLCO

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +16.89% at T+20 after the Oct 1, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $21.14 Now $20.88 −1.23% settles Nov 19
  2. Nov 3, 202613d ago 144 Neutral 2/10 Entry $20.03 to $21.37 Now $20.88 +4.24% ▲ +6.69% +7.28% vs SPY
  3. Oct 29, 202618d ago 144 Neutral 3/10 Entry $20.00 to $19.99 Now $20.88 +4.40% ▼ −0.05% +2.65% vs SPY
  4. Oct 28, 202619d ago 8-K Neutral 2/10 Entry $20.40 to $19.92 Now $20.88 +2.35% ▼ −2.35% +2.37% vs SPY
  5. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $20.40 to $20.60 Now $20.88 +2.35% ▲ +0.98% +1.69% vs SPY
  6. Oct 13, 20264w ago 8-K Mixed 6/10 Entry $15.81 to $16.93 Now $20.88 +32.07% ▲ +7.08% +8.24% vs SPY
  7. Oct 1, 20266w ago Court Ruling Bullish 4/10 Entry $17.11 to $17.30 Now $20.88 +22.03% ▲ +1.11% −0.05% vs SPY
  8. Sep 28, 20267w ago 144 Neutral 2/10 Entry $16.95 to $17.17 Now $20.88 +23.19% ▲ +1.30% +0.09% vs SPY
  9. Aug 14, 202613w ago 3 / CLUSTER Neutral 2/10 Entry $17.00 to $17.32 Now $20.88 +22.82% ▲ +1.88% +3.07% vs SPY
  10. Aug 14, 202613w ago 3 Neutral 2/10 Entry $17.00 to $17.32 Now $20.88 +22.82% ▲ +1.88% +3.07% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (10h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 7, 2026